Balyasny Asset Management LLC Novartis Ag Transaction History

Balyasny Asset Management LLC

  • $72.4 Billion
  • Q3 2025

A detailed history of Balyasny Asset Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Balyasny Asset Management LLC holds 863,633 shares of NVS stock, worth $114 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
863,633
Previous 876,956 1.52%
Holding current value
$114 Million
Previous $106 Million 4.36%
% of portfolio
0.15%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$113.5 - $129.73 $1.51 Million - $1.73 Million
-13,323 Reduced 1.52%
863,633 $111 Million
Q2 2025

Aug 14, 2025
BUY
$101.96 - $121.01 $31 Million - $36.7 Million
303,553 Added 52.94%
876,956 $106 Million
Q1 2025

May 15, 2025
BUY
$97.14 - $115.57 $54 Million - $64.2 Million
555,531 Added 3108.39%
573,403 $63.9 Million
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $1.73 Million - $2.09 Million
17,872 New
17,872 $1.74 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $1.99 Million - $2.31 Million
21,496 Added 175.13%
33,770 $3.6 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $686,706 - $781,851
7,208 Added 142.28%
12,274 $1.19 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $106,202 - $116,872
1,151 Added 29.4%
5,066 $511,000
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $370,867 - $411,583
3,915 New
3,915 $398,000
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $10.3 Million - $11.7 Million
-129,088 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $10.3 Million - $11.4 Million
129,088 New
129,088 $11.3 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $25.3 Million - $29.8 Million
-303,004 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $23.4 Million - $28.3 Million
299,343 Added 8176.54%
303,004 $28.6 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $17.5 Million - $21.5 Million
-231,521 Reduced 98.44%
3,661 $334,000
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $16 Million - $17.8 Million
-217,599 Reduced 48.06%
235,182 $20.2 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $6.74 Million - $7.8 Million
100,695 Added 28.6%
452,781 $39 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $1.09 Million - $1.23 Million
16,799 Added 5.01%
352,086 $26.6 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $17.5 Million - $20.9 Million
248,605 Added 286.8%
335,287 $27.1 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $10.6 Million - $11.4 Million
-146,255 Reduced 62.79%
86,682 $7.28 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $17.3 Million - $18 Million
232,937
232,937 $20 Million

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email